Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 3

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Dermatologic 6Thoracic 3Gastrointestinal 3Genitourinary 2Breast 2Sarcoma 1Gynecologic 1CNS 1

Conditions

Colorectal Neoplasms 14Colonic Neoplasms 7Carcinoma, Hepatocellular 7Breast Neoplasms 7Fatigue 5Prostatic Neoplasms 4Depression 4Vomiting 3Stomach Neoplasms 3Small Cell Lung Carcinoma 3Rectal Neoplasms 3Neoplasms 3Nausea 3Melanoma 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Anxiety Disorders 3Uterine Cervical Neoplasms 2Sarcoma 2Pancreatic Neoplasms 2Pain 2Ovarian Neoplasms 2Esophageal Neoplasms 2Breast Neoplasms, Male 2Anus Neoplasms 2Urinary Bladder Neoplasms 1Unresectable Hepatocellular Carcinoma 1Stress, Psychological 1Sleep Wake Disorders 1Sezary Syndrome 1

Interventions

pembrolizumab 59Nivolumab 34Cyclophosphamide 21fludarabine 15Paclitaxel 12Ipilimumab 12atezolizumab 11Specimen Handling 11Magnetic Resonance Spectroscopy 10Carboplatin 10Docetaxel 9Cisplatin 9Gemcitabine 8Biopsy 8durvalumab 7aldesleukin 7Radiosurgery 7Interleukin-2 7Bevacizumab 7cemiplimab 6Pemetrexed 6fludarabine phosphate 5avelumab 5Radiotherapy 5Drug Therapy 5spartalizumab 4epacadostat 4enzalutamide 4Taxes 4Sirolimus 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Melanoma × Therapeutics × Gastrointestinal × Clear all
NCT06180460 2025-10-08

CALM: Managing Distress in Malignant Brain Cancer

Virginia Commonwealth University

Phase NA Completed
60 enrolled
BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma

NCT00132704 2014-07-24

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Memorial Sloan Kettering Cancer Center

Completed
149 enrolled
DermatologicGastrointestinalGynecologicSarcomaThoracic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Leiomyosarcoma, Liposarcoma, Melanoma, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT00827177 2014-01-24

Dose Escalation Study of ARQ 197 in Combination With Sorafenib in Adult Patients With Advanced Solid Tumors

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)

Phase 1 Completed
87 enrolled
BreastDermatologicGastrointestinalGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Melanoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡